Norcuron

   
Google
 
Web NewDrugInformation.com

Norcuron


Drug - Norcuron
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Vecuronium Bromide
Multiple ingredients are in alphabetical order.

Strength - 10MG/VIAL
The potency of the active ingredient(s), Vecuronium Bromide. May repeat for multiple part products.

Applicant - ORGANON USA INC
The firm name holding legal responsibility for Norcuron. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018776
The FDA assigned number to Norcuron. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Norcuron. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 30, 1984
The date Norcuron was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Norcuron. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Norcuron is in. Format is RX, OTC, DISCN.

Applicant Full Name - Organon Usa Inc
The full name of the firm holding legal responsibility for the new application of Norcuron.

Norcuron